NSC |
Compound |
Enrichment |
Correlation |
NSC 699669 |
Null |
0.00397405528023199 |
0.58909355 |
NSC 700125 |
Null |
0.00397405528023199 |
0.60161238 |
NSC 129794 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.00433056621075589 |
0.26886271 |
NSC 13151 |
Null |
0.00433056621075589 |
0.41360732 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.00433056621075589 |
0.37404096 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.00433056621075589 |
0.47187147 |
NSC 300289 |
Pinafide |
0.00433056621075589 |
0.24993831 |
NSC 303861 |
L-Cysteine analog |
0.00433056621075589 |
0.48392869 |
NSC 30722 |
Pyrimidine, 2,4,6-trichloro-5-methyl- |
0.00433056621075589 |
0.40314918 |
NSC 363813 |
Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- |
0.00433056621075589 |
0.39133092 |